11号染色体长臂缺失（Del11q）阳性的慢性淋巴细胞白血病（CLL）淋巴细胞表现出谷氨酰胺代谢改变以及对谷氨酰胺酶1（GLS1）和葡萄糖代谢抑制的不同反应。 - Suppr

Suppr

超能文献

Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition.

作者信息

Galicia-Vázquez Gabriela, Smith Sarah, Aloyz Raquel

机构信息

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.

出版信息

Blood Cancer J. 2018 Jan 24;8(1):13. doi: 10.1038/s41408-017-0039-2.

DOI:10.1038/s41408-017-0039-2

PMID:29367649

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5802573/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3296/5802573/424b2941cce5/41408_2017_39_Fig1_HTML.jpg

相似文献

Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition.11号染色体长臂缺失（Del11q）阳性的慢性淋巴细胞白血病（CLL）淋巴细胞表现出谷氨酰胺代谢改变以及对谷氨酰胺酶1（GLS1）和葡萄糖代谢抑制的不同反应。

Blood Cancer J. 2018 Jan 24;8(1):13. doi: 10.1038/s41408-017-0039-2.

Insulin receptor activation in deletion 11q chronic lymphocytic leukemia.11q 缺失型慢性淋巴细胞白血病中的胰岛素受体激活。

Clin Cancer Res. 2011 May 1;17(9):2605-7. doi: 10.1158/1078-0432.CCR-11-0295. Epub 2011 Mar 22.

High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome.慢性淋巴细胞白血病患者中11号染色体长臂缺失的荧光原位杂交高百分比是不良预后的独立预测指标。

Am J Hematol. 2015 Jun;90(6):471-7. doi: 10.1002/ajh.23978. Epub 2015 Mar 30.

A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.携带ATM/11q缺失和三体12的B细胞慢性淋巴细胞白血病的一种独特致死性母细胞样转化。

Leuk Res. 2009 Aug;33(8):e124-6. doi: 10.1016/j.leukres.2009.02.008. Epub 2009 Mar 6.

11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.B 细胞慢性淋巴细胞白血病中 11q22.3 缺失与巨大淋巴结病及 ZAP-70 表达特异性相关，但与黏附/细胞表面受体分子表达降低无关。

Leuk Lymphoma. 2006 Feb;47(2):231-44. doi: 10.1080/10428190500254141.

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.两种小鼠模型揭示侵袭性慢性淋巴细胞白血病中存在可靶向治疗的PARP1依赖性。

Nat Commun. 2017 Jul 28;8(1):153. doi: 10.1038/s41467-017-00210-6.

Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病患者中AID、Dicer和Drosha表达的研究。

Immunol Invest. 2017 Jul;46(5):433-446. doi: 10.1080/08820139.2017.1288241. Epub 2017 Apr 7.

Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.伴有11号染色体缺失和12号染色体三体异常的慢性淋巴细胞白血病患者侵袭性疾病的分子基础。

Int J Mol Med. 2007 Oct;20(4):461-9.

Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.无论是否存在11q23缺失，在B细胞慢性淋巴细胞白血病患者中，具有不良临床预后的巨大淋巴结病与ATM下调有关。

Cancer Genet Cytogenet. 2007 Jan 15;172(2):120-6. doi: 10.1016/j.cancergencyto.2006.07.010.

Brain slices from glutaminase-deficient mice metabolize less glutamine: a cellular metabolomic study with carbon 13 NMR.谷氨酸酶缺乏型小鼠的脑切片代谢的谷氨酰胺较少：采用碳 13 NMR 的细胞代谢组学研究。

J Cereb Blood Flow Metab. 2012 May;32(5):816-24. doi: 10.1038/jcbfm.2012.22. Epub 2012 Feb 29.

引用本文的文献

The Critical Role of Adipocytes in Leukemia.脂肪细胞在白血病中的关键作用

Biology (Basel). 2025 May 28;14(6):624. doi: 10.3390/biology14060624.

Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment.急性髓系白血病和急性淋巴细胞白血病的分类及代谢特征，为治疗提供信息并推动治疗进展

Cancers (Basel). 2024 Dec 11;16(24):4136. doi: 10.3390/cancers16244136.

Glutamine and leukemia research: progress and clinical prospects.谷氨酰胺与白血病研究：进展与临床前景

Discov Oncol. 2024 Aug 31;15(1):391. doi: 10.1007/s12672-024-01245-0.

Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.低细胞生物能量代谢是具有不良遗传因素且对BTK抑制反应较好的慢性淋巴细胞白血病患者的特征。

Curr Issues Mol Biol. 2024 May 22;46(6):5085-5099. doi: 10.3390/cimb46060305.

ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.ACOX1 介导的过氧化物酶体脂肪酸氧化有助于慢性淋巴细胞白血病的代谢重编程和存活。

Leukemia. 2024 Feb;38(2):302-317. doi: 10.1038/s41375-023-02103-8. Epub 2023 Dec 6.

Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia.TLR7/8激动剂（瑞喹莫德）对B细胞慢性淋巴细胞白血病中mTOR-HIF-1α轴的调节作用

Indian J Hematol Blood Transfus. 2023 Oct;39(4):537-545. doi: 10.1007/s12288-023-01649-y. Epub 2023 Apr 7.

Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia.谷氨酰胺酶抑制剂CB - 839单独及联合用药治疗慢性淋巴细胞白血病疗效的临床前研究

Front Oncol. 2023 May 9;13:1161254. doi: 10.3389/fonc.2023.1161254. eCollection 2023.

Emerging Therapies in CLL in the Era of Precision Medicine.精准医学时代慢性淋巴细胞白血病的新兴疗法

Cancers (Basel). 2023 Mar 3;15(5):1583. doi: 10.3390/cancers15051583.

Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.代谢组学：B细胞非霍奇金淋巴瘤诊断或预后的新时代。

Diagnostics (Basel). 2023 Feb 23;13(5):861. doi: 10.3390/diagnostics13050861.

Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?治疗B细胞恶性肿瘤新型药物的现状：接下来会有什么进展？

Cancers (Basel). 2022 Dec 7;14(24):6026. doi: 10.3390/cancers14246026.

本文引用的文献

B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia.B 细胞受体信号转导调控慢性淋巴细胞白血病的代谢。

Mol Cancer Res. 2017 Dec;15(12):1692-1703. doi: 10.1158/1541-7786.MCR-17-0026. Epub 2017 Aug 23.

The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.谷氨酸/胱氨酸 xCT 载体拮抗谷氨酰胺代谢，降低营养灵活性。

Nat Commun. 2017 Apr 21;8:15074. doi: 10.1038/ncomms15074.

Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia.依鲁替尼诱导慢性淋巴细胞白血病细胞凋亡的细胞内在决定因素

Clin Cancer Res. 2017 Feb 15;23(4):1049-1059. doi: 10.1158/1078-0432.CCR-15-2921. Epub 2016 Aug 17.

Targeted therapies in CLL: mechanisms of resistance and strategies for management.慢性淋巴细胞白血病的靶向治疗：耐药机制与管理策略

Blood. 2015 Jul 23;126(4):471-7. doi: 10.1182/blood-2015-03-585075. Epub 2015 Jun 11.

Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.联合抑制糖酵解、戊糖循环和硫氧还蛋白代谢可选择性地增加人乳腺癌和前列腺癌的细胞毒性及氧化应激。

Redox Biol. 2015;4:127-35. doi: 10.1016/j.redox.2014.12.001. Epub 2014 Dec 10.

Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.使用美国食品药品监督管理局（FDA）批准的利托那韦和二甲双胍靶向多发性骨髓瘤的代谢可塑性。

Clin Cancer Res. 2015 Mar 1;21(5):1161-71. doi: 10.1158/1078-0432.CCR-14-1088. Epub 2014 Dec 26.

Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification.葡萄糖和谷氨酰胺代谢调节人类造血干细胞谱系的特化。

Cell Stem Cell. 2014 Aug 7;15(2):169-84. doi: 10.1016/j.stem.2014.06.002. Epub 2014 Jun 19.

Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.原发性慢性淋巴细胞白血病淋巴细胞对达沙替尼的耐药性涉及AMPK介导的能量重编程。

Oncotarget. 2013 Dec;4(12):2550-66. doi: 10.18632/oncotarget.1508.

The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.慢性淋巴细胞白血病中 miR-125b 的下调导致细胞向转化状态的代谢适应。

Blood. 2012 Sep 27;120(13):2631-8. doi: 10.1182/blood-2012-03-415737. Epub 2012 Jun 21.

ATM is a redox sensor linking genome stability and carbon metabolism.ATM 是连接基因组稳定性和碳代谢的氧化还原传感器。

Sci Signal. 2011 Apr 5;4(167):pe17. doi: 10.1126/scisignal.2001959.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验